Cargando…
MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis
Acute myeloid leukemia (AML) is one of the most common hematological malignancies all around the world. MicroRNAs have been determined to contribute various cancers initiation and progression, including AML. Although microRNA-204 (miR-204) exerts anti-tumor effects in several kinds of cancers, its f...
Autores principales: | Wang, Zhiguo, Luo, Hong, Fang, Zehui, Fan, Yanling, Liu, Xiaojuan, Zhang, Yujing, Rui, Shuping, Chen, Yafeng, Hong, Luojia, Gao, Jincheng, Zhang, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177501/ https://www.ncbi.nlm.nih.gov/pubmed/29764561 http://dx.doi.org/10.5483/BMBRep.2018.51.9.036 |
Ejemplares similares
-
MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide
por: Wang, Zhiguo, et al.
Publicado: (2019) -
Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2015) -
Myeloid ecotropic viral integration site-1 inhibition promotes apoptosis, suppresses proliferation of acute myeloid leukemia cells, accentuates the effects of anticancer drugs
por: Jin, Yinglan, et al.
Publicado: (2022) -
miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
por: Chen, Zhiyu, et al.
Publicado: (2013) -
BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation
por: Schläfli, Anna M, et al.
Publicado: (2012)